RxDoctor Payments Data

Helen Arnold, DO

Family Medicine · Newport News, VANPI 1962858944

Payments from drug & device makers

$511in general payments, 2019–2025

Across 29 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$72
  • Amgen$67
  • Amarin Pharma, Inc.$63
  • AbbVie$61
  • AstraZeneca$61
  • Astellas Pharma US Inc$56
  • plus $130 from 8 others

What the payments were for

  • Food & beverage$49096%
  • Education$214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$511 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$42,526
Medicare patients
81
Services billed
956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide20$41,046
EliquisApixaban31$30,582
MounjaroTirzepatide29$30,169
OzempicSemaglutide29$27,842
WegovySemaglutide11$14,596
Spiriva HandihalerTiotropium Bromide19$14,353
TrulicityDulaglutide11$10,064
Potassium Chloride21$3,059
SymbicortBudesonide/Formoterol Fumarate11$2,791
Duloxetine Hcl115$2,492
Tizanidine Hcl21$2,189
Albuterol Sulfate HfaAlbuterol Sulfate62$2,137
Diclofenac Sodium31$1,256
Bupropion XlBupropion Hcl69$1,238
Atorvastatin Calcium123$1,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$12$40,23340 claims
PfizerEliquis$21$30,58231 claims
AstraZenecaSymbicort$61$2,79111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →